Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.

× No keyword cloud information.

36 in total

1. Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration.

Authors: J Stuart Nelson; Wangcun Jia; Thuy L Phung; Martin C Mihm
Journal: Lasers Surg Med Date: 2011-11-29 Impact factor: 4.025

Review 2. The horizon for treating cutaneous vascular lesions.

Authors: Amit M Patel; Elizabeth L Chou; Laura Findeiss; Kristen M Kelly
Journal: Semin Cutan Med Surg Date: 2012-06

3. Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.

Authors: Guillaume Le Guyader; Victoire Vieillard; Karine Andrieux; Mylène Rollo; Olivier Thirion; Pierre Wolkenstein; Muriel Paul
Journal: Eur J Hosp Pharm Date: 2018-11-10

4. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.

Authors: Mari Wataya-Kaneda; Yuuki Ohno; Yasuyuki Fujita; Hiroo Yokozeki; Hironori Niizeki; Masaaki Ogai; Kazuyoshi Fukai; Hiroshi Nagai; Yuichi Yoshida; Izumi Hamada; Taihei Hio; Kenji Shimizu; Hiroyuki Murota
Journal: JAMA Dermatol Date: 2018-07-01 Impact factor: 10.282

5. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.

Authors: Mary Kay Koenig; Cynthia S Bell; Adelaide A Hebert; Joan Roberson; Joshua A Samuels; John M Slopis; Patti Tate; Hope Northrup
Journal: JAMA Dermatol Date: 2018-07-01 Impact factor: 10.282

Review 6. mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology.

Authors: Anna Jeong; Michael Wong
Journal: Curr Neurol Neurosci Rep Date: 2016-12 Impact factor: 5.081

7. Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex.

Authors: Darcy A Krueger
Journal: Curr Treat Options Neurol Date: 2013-10 Impact factor: 3.598

Review 8. The neurology of mTOR.

Authors: Jonathan O Lipton; Mustafa Sahin
Journal: Neuron Date: 2014-10-22 Impact factor: 17.173

9. Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future.

Authors: Jack L Arbiser
Journal: JAMA Dermatol Date: 2015-07 Impact factor: 10.282

10. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels.

Authors: Wenbin Tan; Wangcun Jia; Victor Sun; Martin C Mihm; J Stuart Nelson
Journal: Lasers Surg Med Date: 2012-12-04 Impact factor: 4.025